Ornithine decarboxylase activity in rabbit retina following treatment with alpha-difluoromethylornithine

Biochem Pharmacol. 1987 Dec 15;36(24):4325-9. doi: 10.1016/0006-2952(87)90679-4.

Abstract

The rabbit retina has been utilized as a model for the study of abnormal cellular proliferation on the retinal surface and into the vitreous, a process commonly initiated by trauma and generally leading to retinal detachment. This study characterizes the ability of alpha-difluoromethylornithine (alpha-DFMO), a suicide inactivator of L-ornithine decarboxylase (EC 4.1.1.17) to inactivate normal retinal ornithine decarboxylase (ODC) activity in the crude supernatant fraction after incubation with different concentrations of alpha-DFMO and at various times after intraocular administration. Partial inactivation of ODC activity occurred following preincubation of crude retinal supernatant fraction with 10(-5) M alpha-DFMO (N = 3; 34 +/- 6.9% of control), whereas preincubation with 10(-8) M alpha-DFMO did not alter ODC activity significantly (N = 3; 94 +/- 2% of control). Different concentrations of alpha-DFMO administered intraocularly inactivated retinal ODC activity to varying degrees with different rates of recovery. No gross toxicity occurred with ocular tissues following intravitreal administration of alpha-DFMO as determined by electrophysiologic measurements, by indirect examination of the retina, and by measurement of intraocular pressure. These results suggest that alpha-DFMO may be a useful tool in which to define the physiologic role of ODC and polyamines in intraocular cellular proliferative diseases.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Division / drug effects
  • Dose-Response Relationship, Drug
  • Eflornithine / administration & dosage
  • Eflornithine / pharmacology*
  • In Vitro Techniques
  • Ornithine Decarboxylase Inhibitors*
  • Rabbits
  • Retina / enzymology*
  • Time Factors

Substances

  • Ornithine Decarboxylase Inhibitors
  • Eflornithine